Skip to main content
Erschienen in: Tumor Biology 4/2016

15.11.2015 | Original Article

TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma

verfasst von: Xin Li

Erschienen in: Tumor Biology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Tumor-associated macrophages (TAMs) play an essential role in the immunology, growth, invasion, and metastases of skin squamous cell carcinoma (SCC). However, the molecular mechanisms underlying the activation and regulation of TAMs by SCC are not completely understood. Here, in a Transwell co-culture system, we found that SCC cells induced polarization of macrophages to a M2 phenotype, evident by expression of surface markers CD163, CD206, and CD301, as well as reduction of cellular iNOS levels and augmentation of cellular arginase levels. Moreover, tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 (TIPE2) was induced in macrophages by co-culturing with SCC cells. Depletion of TIPE2 in macrophages abolished the effects of co-cultured SCC cells on phenotypic modification of macrophages. Furthermore, patients with SCC were divided into two groups based on TIPE2 levels in TAMs at the time of tumor resection. We found that patients with high-TIPE2 TAMs had an overall poor 5-year survival. Together, our data suggest a previously unappreciated role of TIPE2 in the crosstalk between skin SCC and TAMs and highlight TIPE2 as a promising novel target for skin SCC treatment.
Literatur
1.
Zurück zum Zitat Rahimi S. Squamous cell carcinoma of skin: a brief review. Clin Ter. 2013;164:143–7.PubMed Rahimi S. Squamous cell carcinoma of skin: a brief review. Clin Ter. 2013;164:143–7.PubMed
2.
Zurück zum Zitat Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010;10:554–67.CrossRefPubMed Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010;10:554–67.CrossRefPubMed
3.
Zurück zum Zitat Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953–64.CrossRefPubMed Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953–64.CrossRefPubMed
5.
Zurück zum Zitat Grunewald M, Avraham I, Dor Y, et al. Vegf-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell. 2006;124:175–89.CrossRefPubMed Grunewald M, Avraham I, Dor Y, et al. Vegf-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell. 2006;124:175–89.CrossRefPubMed
6.
Zurück zum Zitat Xiao X, Gaffar I, Guo P, et al. M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.CrossRefPubMedPubMedCentral Xiao X, Gaffar I, Guo P, et al. M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Liu W, Zhang S, Gu S, Sang L, Dai C. Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through tgfbeta1. Cell Physiol Biochem. 2015;35:858–65.CrossRefPubMed Liu W, Zhang S, Gu S, Sang L, Dai C. Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through tgfbeta1. Cell Physiol Biochem. 2015;35:858–65.CrossRefPubMed
8.
Zurück zum Zitat Wang B, Miao Y, Zhao Z, Zhong Y. Inflammatory macrophages promotes development of diabetic encephalopathy. Cell Physiol Biochem. 2015;36:1142–50.CrossRefPubMed Wang B, Miao Y, Zhao Z, Zhong Y. Inflammatory macrophages promotes development of diabetic encephalopathy. Cell Physiol Biochem. 2015;36:1142–50.CrossRefPubMed
9.
Zurück zum Zitat Shen B, Liu X, Fan Y, Qiu J. Macrophages regulate renal fibrosis through modulating tgfbeta superfamily signaling. Inflammation. 2014;37:2076–84.CrossRefPubMed Shen B, Liu X, Fan Y, Qiu J. Macrophages regulate renal fibrosis through modulating tgfbeta superfamily signaling. Inflammation. 2014;37:2076–84.CrossRefPubMed
10.
Zurück zum Zitat Song X, Xie S, Lu K, Wang C. Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation. 2015;38:485–92.CrossRefPubMed Song X, Xie S, Lu K, Wang C. Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation. 2015;38:485–92.CrossRefPubMed
11.
Zurück zum Zitat Cao X, Han ZB, Zhao H, Liu Q. Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice. Int J Biochem Cell Biol. 2014;53:372–9.CrossRefPubMed Cao X, Han ZB, Zhao H, Liu Q. Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice. Int J Biochem Cell Biol. 2014;53:372–9.CrossRefPubMed
13.
Zurück zum Zitat Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231–7.CrossRefPubMed Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231–7.CrossRefPubMed
14.
Zurück zum Zitat Zhang X, Wang J, Fan C, et al. Crystal structure of tipe2 provides insights into immune homeostasis. Nat Struct Mol Biol. 2009;16:89–90.CrossRefPubMed Zhang X, Wang J, Fan C, et al. Crystal structure of tipe2 provides insights into immune homeostasis. Nat Struct Mol Biol. 2009;16:89–90.CrossRefPubMed
15.
Zurück zum Zitat Sun H, Gong S, Carmody RJ, et al. Tipe2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008;133:415–26.CrossRefPubMedPubMedCentral Sun H, Gong S, Carmody RJ, et al. Tipe2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008;133:415–26.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lou Y, Zhang G, Geng M, Zhang W, Cui J, Liu S. Tipe2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase. PLoS ONE. 2014;9:e96508.CrossRefPubMedPubMedCentral Lou Y, Zhang G, Geng M, Zhang W, Cui J, Liu S. Tipe2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase. PLoS ONE. 2014;9:e96508.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Xiao Q, Zhang X, Wu Y, Yang Y. Inhibition of macrophage polarization prohibits growth of human osteosarcoma. Tumour Biol. 2014;35:7611–6.CrossRefPubMed Xiao Q, Zhang X, Wu Y, Yang Y. Inhibition of macrophage polarization prohibits growth of human osteosarcoma. Tumour Biol. 2014;35:7611–6.CrossRefPubMed
18.
Zurück zum Zitat Pan B, Liu G, Jiang Z, Zheng D. Regulation of renal fibrosis by macrophage polarization. Cell Physiol Biochem. 2015;35:1062–9.CrossRefPubMed Pan B, Liu G, Jiang Z, Zheng D. Regulation of renal fibrosis by macrophage polarization. Cell Physiol Biochem. 2015;35:1062–9.CrossRefPubMed
19.
Zurück zum Zitat Lin S, Qiu M, Chen J. Il-4 modulates macrophage polarization in ankylosing spondylitis. Cell Physiol Biochem. 2015;35:2213–22.CrossRefPubMed Lin S, Qiu M, Chen J. Il-4 modulates macrophage polarization in ankylosing spondylitis. Cell Physiol Biochem. 2015;35:2213–22.CrossRefPubMed
20.
Zurück zum Zitat Liu S, Chen M, Li P, et al. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell Physiol Biochem. 2015;36:499–508.CrossRefPubMed Liu S, Chen M, Li P, et al. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell Physiol Biochem. 2015;36:499–508.CrossRefPubMed
21.
Zurück zum Zitat Liu S, Gong Z, Chen M, Liu B, Bian D, Wu K. Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma. Tumour Biol. 2014;35:11605–12.CrossRefPubMed Liu S, Gong Z, Chen M, Liu B, Bian D, Wu K. Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma. Tumour Biol. 2014;35:11605–12.CrossRefPubMed
22.
Zurück zum Zitat Zhou X, Qi Y. Plgf inhibition impairs metastasis of larynx carcinoma through mmp3 downregulation. Tumour Biol. 2014;35:9381–6.CrossRefPubMed Zhou X, Qi Y. Plgf inhibition impairs metastasis of larynx carcinoma through mmp3 downregulation. Tumour Biol. 2014;35:9381–6.CrossRefPubMed
23.
Zurück zum Zitat Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013;123:3190–200.CrossRefPubMedPubMedCentral Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013;123:3190–200.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yang Y, Sun M, Wang L, Jiao B. HIFs, angiogenesis, and cancer. J Cell Biochem. 2013;114:967–74.CrossRefPubMed Yang Y, Sun M, Wang L, Jiao B. HIFs, angiogenesis, and cancer. J Cell Biochem. 2013;114:967–74.CrossRefPubMed
Metadaten
Titel
TIPE2 regulates tumor-associated macrophages in skin squamous cell carcinoma
verfasst von
Xin Li
Publikationsdatum
15.11.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4388-9

Weitere Artikel der Ausgabe 4/2016

Tumor Biology 4/2016 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.